Drug-drug interaction study of SMP-508 and sitagliptin.
Phase 1
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-jRCT2080221771
- Lead Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Male
- Target Recruitment
- 24
Inclusion Criteria
Subject
Healthy adult male volunteers
Inclusion criteria
- Subjects who provided written informed consent to participate in the study.
- Subjects whose body weight are between 50.0 and 80.0 kg and whose body mass index (BMI) are 18.5 to 25.0 {BMI = body weight (kg) / [height (m)]2}
etc.
Exclusion Criteria
Exclusion criteria
- Subjects with a history of drug allergies.
- Subjects with any alcohol abuse.
etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method